Concepedia

Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors

Marek Samochocki, Anja Höffle, Andreas Fehrenbacher, Ruth Jostock, Jürgen Ludwig, Claudia Christner, Martin Radina, Marion Zerlin, Christoph Ullmer, Edna F. R. Pereira,

Journal of Pharmacology and Experimental Therapeutics · 2003 · 335 citations · 33 references

DOI

Concepts

References

33

Galantamine in AD

Murray A. Raskind, Elaine R. Peskind, Thomas Wessel et al. · Neurology · 2000 · 871 citations

, , +17

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

G K Wilcock, Sean Lilienfeld, E. Gaens · BMJ · 2000 · 629 citations · Full text

, , +15

Chimaeric nicotinic–serotonergic receptor combines distinct ligand binding and channel specificities

Jean-Luc Eiselé, Sonia Bertrand, Jean‐Luc Galzi et al. · Nature · 1993 · 408 citations

, , +12

Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.

André Schrattenholz, Edna F. R. Pereira, U Roth et al. · Molecular Pharmacology · 1996 · 228 citations

, , +17

Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease

Alfred Maelicke, Edson X. Albuquerque · European Journal of Pharmacology · 2000 · 221 citations

, , +16